الفهرس 
Introduction and RationaleOnly 14 pages are availabe for public view
 |  | from | 120 |  |  |
| | | from | 120 | | |
Abstract
No significant effects on heart rate were recorded with sugammadex; however, neostigmine caused significant increases in the mean heart rate in the first, second and third minutes after administration.
A significant decrease in recovery time was noted in the sugamadex group compared to the neostigmine group as noted in times to reach TOF and time to extubation.
Other complications were also notes with the use of neostigmine shown as tachycardia, hypersalivation, bronchoconstriction and Recurarization however the data were statistically insignificant as the sample size is small. It is expected to be significant with a larger such sample.
Sugammadex showed better results and fewer complications as expected in the study hypothesis.
Cases with Recurarization in neostigmine group were closely monitored and were re-intubated.